Ovation iX Iliac Stent Graft TV-IL1418140-JRecalls & reported problems
Endologix LLC · The Ovation iX™ Iliac Limbs are components of the Ovation Prime, Ovation iX, and Alto™ Abdominal Stent Graft Systems. The Ovation iX™ Iliac Limbs are comprised of a nitinol stent encapsulated in low-permeability PTFE. The iliac limbs are deployed into the leg sections of the aortic body. Additional iliac limbs may be used to extend the length of the device, where indicated. · Class 3 · Implant
All models of Ovation iX Iliac Stent Graft (66)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 7
- Deaths reported
- 0
- Injuries reported
- 7
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 7 adverse event reports that list this exact device (DI 00850007370305), received between May 19, 2022 and Apr 29, 2026 — classified as 7 injuries.
The most frequently reported specific device problem is “Obstruction of Flow” (3 reports).
3 other recalls cover devices cleared under the same FDA submission (P120006); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Obstruction of Flow3
- Complete Blockage1
- Device Stenosis1
- Improper or Incorrect Procedure or Method1
- Lack of Effect1
- Malposition of Device1
- Off-Label Use1
- Positioning Failure1
Patient problems
- Obstruction/Occlusion4
- Clinical Endoleak1
- Ischemia1
- No Clinical Signs, Symptoms or Conditions1
- Stenosis1
- Thrombosis/Thrombus1
Recent adverse event reports
The 7 most recent of 7 reports, in the reporter's own words as published by the FDA.
InjuryApr 29, 2026Obstruction of Flow
THE PATIENT WAS INITIALLY TREATED FOR AN ABDOMINAL AORTIC ANEURYSM (AAA) ON (B)(6) 2025 WITH THE IMPLANT OF AN ALTO ABDOMINAL STENT GRAFT SYSTEM. IT WAS REPORTED THAT THE PROCEDURE WAS PERFORMED FOR A FUSIFORM ANEURYSM WITH A LONG NECK AND NARROW ACCESS VESSELS. THE ALTO MAIN BODY WAS DEPLOYED VIA LEFT ACCESS. THE CONTRALATERAL LEG OF THE ALTO MAIN BODY WAS ORIENTED TO THE ANTERIOR/POSTERIOR DIRECTION, RESULTING IN A CROSS-LEGGED (BALLERINA) CONFIGURATION. THE CUSTOMSEAL POLYMER FILL WAS DELIVERED WITHOUT ANY ISSUES. CONTRALATERAL CANNULATION WAS ACHIEVED SUCCESSFULLY IN APPROXIMATELY FOUR MINUTES. THE OVATION IX ILIAC LIMB STENT GRAFT WAS DEPLOYED IN THE RIGHT COMMON ILIAC ARTERY (CIA), FOLLOWED BY TOUCH-UP USING THE INTEGRATED BALLOON 14 MINUTES LATER. NEXT THE OTHER OVATION IX ILIAC LIMB STENT GRAFT WAS DEPLOYED IN THE LEFT CIA, FOLLOWED BY BALLOON TOUCH-UP. THE PROCEDURE WAS COMPLETED WITH NO ENDOLEAKS OR FLOW DELAYS CONFIRMED. ROUTINE FOLLOW-UP APPROXIMATELY THREE MONTHS LATER ON (B)(6) 2026 CONDUCTED A COMPUTED TOMOGRAPHY (CT) SCAN THAT REVEALED THROMBOTIC OCCLUSION OF THE RIGHT CIA LIMB (FROM THE PROXIMAL TO THE DISTAL END) AS WELL AS OCCLUSION OF THE PROXIMAL SECTION OF THE
Patient problems: Obstruction/Occlusion; Thrombosis/Thrombus
MAUDE report 25034415 ↗InjuryAug 13, 2025Positioning Failure; Off-Label Use; Positioning Failure; Off-Label Use
THE PATIENT WAS TREATED WITH THE IMPLANT OF AN AFX2 BIFURCATED STENT GRAFT (BSG), AN AFX VELA SUPRARENAL, TWO OVATION IX ILIAC LIMBS, AND AN OVATION IX EXTENDER ON (B)(6) 2022. APPROXIMATELY TWO YEARS AFTER THE INITIAL PROCEDURE, INTERVENTION WAS COMPLETED ON (B)(6) 2024 WITH THE IMPLANT OF AN AFX2 BSG AN AFX VELA INFRARENAL, AND AN OVATION IX ILIAC LIMB TO TREAT ANEURYSM ENLARGEMENT, A TYPE IB ENDOLEAK OF THE RIGHT COMMON ILIAC (RCI) ARTERY, TYPE IIIB ENDOLEAK OF THE DISTAL MAIN BODY, AND LOSS OF OVERLAP OF THE LEFT OVATION IX ILIAC LIMB FROM THE AFX2 BSG. (REPORTED UNDER MFR# 3011063223-2024-00120). APPROXIMATELY ONE YEAR POST INTERVENTION, DURING A PROCEDURE TO TREAT AN UNRELATED HEART ISSUE, THE CATHETER PUSHED THE AFX2 BSG UP AND THE OVATION IX EXTENDER IN THE RCI SLIPPED OUT OF THE AFX2 BSG CAUSING A TYPE IB ENDOLEAK. REINTERVENTION OCCURRED ON (B)(6) 2025. REPORTEDLY, THE ILIAC WAS TORTUOUS. THE PHYSICIAN MADE MULTIPLE ATTEMPTS TO KEEP THE RIGHT ILIAC OPEN BUT FAILED AND WAS UNABLE TO PLACE A NEW, RIGHT COMMON ILIAC ARTERY GRAFT. THE PROCEDURE CONVERTED TO AN AORTO-UNI-I LIAC (AUI) WITH A LEFT TO RIGHT FEMORAL BYPASS. THE PATIENT WAS REPORTED AS HAVING NO ABDOMINAL PAIN AND
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 22797424 ↗InjuryMay 29, 2025Lack of Effect; Lack of Effect
THE PATIENT WAS INITIALLY TREATED FOR AN ABDOMINAL AORTIC ANEURYSM (AAA) ON (B)(6) 2023 WITH THE IMPLANT OF AN ALTO ABDOMINAL STENT GRAFT SYSTEM. APPROXIMATELY ONE (1) MONTH POST INITIAL PROCEDURE, THE PATIENT PRESENTED WITH A PROXIMAL RIGHT ILIAC STENT COMPRESSION (GREATER THAN 50 PERCENT), BILATERAL TYPE IB ENDOLEAKS AND OUTFLOW TO THE LUMBAR ARTERIES (CLASSIFIED AS A NON-DEVICE-RELATED TYPE II ENDOLEAK). BOTH LIMBS WERE PULLED UP PROXIMALLY BEYOND THE MARGINS OF THE VERY SHORT COMMON ILIACS RESULTING IN THE BILATERAL TYPE 1B ENDOLEAKS. THE PHYSICIAN ELECTED TO RE-INTERVENE AND EXTENDED BILATERALLY WITH OVATION IX ILIAC LIMBS ON (B)(6) 2023 TO RESOLVE THIS EVENT. (REPORTED TO THE FDA ON MDR# 3008011247-2023-00067). ROUTINE FOLLOW-UP CONDUCTED ON (B)(6) 2025 IDENTIFIED THAT THE RIGHT COMMON IS NOW ANEURYSMAL AND THE OVATION IX ILIAC LIMB NO LONGER HAS PURCHASE RESULTING IN A TYPE IB ENDOLEAK. REPORTEDLY, THE PATIENT HAD A SHORT ECTATIC COMMON ILIAC AND ON THE INITIAL ANGIOGRAM IT WAS DETERMINED THAT THE INTERNAL ILIAC ON THE RIGHT SIDE WAS NOT PATENT. REINTERVENTION WAS COMPLETED ON (B)(6) 2025 WITH THE IMPLANT OF AN OVATION IX ILIAC LIMB STENT GRAFT. THE PROXIMAL PLACEMENT WAS AT
Patient problems: Clinical Endoleak
MAUDE report 22107334 ↗InjuryMar 11, 2025Obstruction of Flow; Obstruction of Flow
THE PATIENT WAS IMPLANTED WITH THE ALTO STENT GRAFT SYSTEM TO TREAT AN ABDOMINAL AORTIC ANEURYSM (AAA) ON (B)(6) 2024. APPROXIMATELY THREE (3) MONTHS AFTER THE INITIAL PROCEDURE, A LIMB OCCLUSION WAS DETECTED, REQUIRING AN ADDITIONAL FEMORAL-FEMORAL BYPASS SURGICAL PROCEDURE TO RESTORE BLOOD FLOW. THE FINAL PATIENT STATUS REMAINS UNKNOWN, AS IT WAS NOT MADE AVAILABLE TO ENDOLOGIX.
Patient problems: Obstruction/Occlusion
MAUDE report 21574169 ↗InjuryMay 3, 2024Improper or Incorrect Procedure or Method; Obstruction of Flow; Malposition of Device; Improper or Incorrect Procedure or Method; Obstruction of Flow; Malposition of Device
THE PATIENT WAS IMPLANTED WITH THE ALTO STENT GRAFT SYSTEM TO TREAT AN ABDOMINAL AORTIC ANEURYSM (AAA) ON (B)(6) 2024. IT WAS REPORTED THAT THE PROCEDURE WAS CHALLENGING DUE TO ANGULATION AND A SHORT NECK. DESPITE THESE OBSTACLES, THE PHYSICIAN MANAGED TO IMPLANT THE ALTO STENT GRAFT AND PERFORM BALLOON DILATION 16 MINUTES AFTER POLYMER MIXING. BOTH LIMBS WERE POSITIONED WITHOUT DIFFICULTY. FOLLOWING THE IMPLANTATION, THERE WAS A NOTABLE AGGRESSIVE TYPE IA ENDOLEAK. TO ADDRESS THIS, A (NON-ENDOLOGIX) PALMAZ P4010 WITH A NEW CODA BALLOON WAS INTRODUCED, BUT THE IA ENDOLEAK PERSISTED AT A REDUCED RATE. ADDITIONAL ATTEMPTS WITH A Q50 BALLOON AND ZMED 25X40 BALLOON WERE UNSUCCESSFUL IN COMPLETELY HALTING THE IA ENDOLEAK. AS A FINAL MEASURE, A (NON-ENDOLOGIX) GORE EXCLUDER EXTENSION WAS DEPLOYED, RESULTING IN A SIGNIFICANT REDUCTION IN THE IA ENDOLEAK REPORTED UNDER MFR# 3008011247-2024-00018. ON FEBRUARY 27, 2024, THE PATIENT PRESENTED TO THE EMERGENCY ROOM WITH BILATERAL LEG PAIN. IT WAS REPORTED THAT THE LEFT LOWER EXTREMITY APPEARED COLD, PALE, AND MOTTLED FROM THE KNEE DOWNWARDS WITH AN ABSENT DISTAL PULSE. THE LEFT COMMON ILIAC ARTERY (LCIA) WAS OCCLUDED, AND THERE WAS PARTIAL OCC
Patient problems: Ischemia; Obstruction/Occlusion
MAUDE report 19241824 ↗InjuryDec 12, 2023Device Stenosis; Device Stenosis
THE PATIENT WAS IMPLANTED WITH THE ALTO STENT GRAFT SYSTEM TO TREAT AN ABDOMINAL AORTIC ANEURYSM (AAA). DURING THIS INITIAL PROCEDURE, THE INFERIOR MESENTERIC ARTERY (IMA WAS INTENTIONALLY OCCLUDED. AFTER IMPLANT OF THE ALTO MAIN BODY THERE WAS NO TYPE 1A ENDOLEAK NOTED. THE CONTRALATERAL LIMB WAS IMPLANTED ON THE RIGHT SIDE. DURING INSERTION OF THE IPSILATERAL ILIAC LIMB ON THE LEFT SIDE, THE ALTO MAIN BODY MOVED SLIGHTLY; HOWEVER, THE PHYSICIAN CONTINUED THE IMPLANT OF THE LIMB FOLLOWED BY AN ILIAC EXTENSION ON THE RIGHT SIDE. AN INDETERMINATE ENDOLEAK WAS OBSERVED AND THE PHYSICIAN DECIDED TO MONITOR THE PATIENT NOT TO PERFORM ANY FURTHER TREATMENT AT THAT TIME. REFERENCE MFR # 3008011247-2023-00198 FOR THIS EVENT. APPROXIMATELY THREE OR FOUR DAYS POST INITIAL PROCEDURE A CONTRAST COMPUTED TOMOGRAPHY (CT) WAS TAKEN PRIOR TO PATIENT DISCHARGE AND SHOWED LEFT LIMB STENOSIS AROUND THE TERMINAL AORTA. AN EMERGENCY INTERVENTION WAS PERFORMED AT THAT TIME AND A BARE STENT WAS IMPLANTED ON THE LEFT LIMB. IT WAS REPORTED THAT THE SIX (6) MONTH FOLLOW-UP CONTRAST CT SHOWED A POSSIBLE TYPE 1A ENDOLEAK. THE PATIENT WAS ADMITTED TO THE HOSPITAL ON (B)(6) 2023 FOR ADDITIONAL EVALUATION AND T
Patient problems: Stenosis
MAUDE report 18312848 ↗InjuryMay 19, 2022Complete Blockage; Complete Blockage
THE PATIENT WAS INITIALLY TREATED FOR AN ABDOMINAL AORTIC ANEURYSM (AAA) WITH THE ALTO STENT GRAFT SYSTEM (ONE (1) ALTO MAIN BODY AND TWO (2) OVATION IX ILIAC LIMBS). APPROXIMATELY ONE (1) MONTH POST INITIAL PROCEDURE, OCCLUSION OF THE LIMB WAS IDENTIFIED AT ROUTINE FOLLOW-UP. REINTERVENTION WAS COMPLETED WITH THE IMPLANT OF THREE (3) OVATION IX ILIAC LIMBS. THE PATIENT WAS REPORTED TO BE DOING WELL POST REINTERVENTION.
Patient problems: Obstruction/Occlusion
MAUDE report 14435373 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under P120006. One submission often covers many models, so check the product and lot details in each record.
- Z-2263-2020 · May 6, 2020 · TerminatedOvation iX Abdominal Stent Graft Systems, REF: TV-AB2080-I, TV-AB2080-J, TV-AB2380-I, TV-AB2380-J, TV-AB2680-I, TV-AB2680-J, TV-AB2980-I, TV-AB2980-J, TV-AB3480-I, TV-AB3480-J
- Z-0125-2015 · Sep 20, 2014 · TerminatedOvation Prime Abdominal Stent Graft System - 29mm Aortic Body stent grafts. The TriVascular Ovation Prime Abdominal Stent Graft System is a low-profile endovascular device deliver
- Z-0288-2013 · Oct 19, 2012 · TerminatedTriVascular brand Fill Polymer Kit, Endovascular Graft, Aneurysm Treatment System, European Model Number: TVFP14-B, (in European distributor inventory only); PRODUCT Usage: The
Other System, Endovascular Graft, Aortic Aneurysm Treatment devices
- Endurant® IIs ESBF2814C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls34 deaths254 reports
- Endurant® IIs ESBF3214C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls19 deaths173 reports
- Endurant® IIs ESBF3614C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT1 recall37 deaths214 reports
- Endurant® IIs ESBF2514C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls18 deaths136 reports
- Endurant® IIs ESBF2314C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls9 deaths60 reports
- RelayPro Thoracic Stent-Graft System 28-N4-34-154-34UBolton Medical Inc. · System, Endovascular Graft, Aortic Aneurysm Treatment3 recalls7 reports
- Vela Proximal Endograft System A34-34/C100-O20 VEndologix LLC · System, Endovascular Graft, Aortic Aneurysm Treatment3 deaths152 reports
- Endurant® II ETCF2828C49EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls7 deaths44 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page